New Delhi, Sept. 10 -- Molbio Diagnostics share price was locked in a 20% upper circuit on Thursday, 10 September, extending its strong rally since its stock market debut. Listed on 17 August 2026, the stock has surged nearly 87% from its IPO price of Rs.807 per share and has touched an all-time high of Rs.1,509.70 on the BSE today.

Market experts remain positive on the company's long-term prospects, citing its leadership in molecular diagnostics, expansion-led growth strategy and favourable industry outlook. However, given the sharp gains since its market debut, experts have advised investors to remain disciplined.

The positive sentiment follows Molbio Diagnostics' strong performance in the June quarter. On 7 September, the company rep...